A Case of Prolonged Cholestatic Hepatitis Induced by Azithromycin in a Young Woman
Open Access
- 1 January 2011
- journal article
- case report
- Published by Hindawi Limited in Case Reports in Hepatology
- Vol. 2011 (3), 1-4
- https://doi.org/10.1155/2011/314231
Abstract
Azithromycin, a semisynthetic macrolides, is frequently prescribed for the treatment of middle ear and upper respiratory tract infections, bronchitis, and community-acquired pneumonia. This antibiotic is usually well tolerated, and a rapid resolving cholestatic hepatitis has been described up to now only in six patients all, except one, over 65 years of age. We here report the case of a prolonged cholestatic hepatitis after administration of azithromycin in a young woman with no history of liver disease.Keywords
This publication has 14 references indexed in Scilit:
- Characteristics of Idiosyncratic Drug‐induced Liver Injury in ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2011
- Azithromycin-induced liver injuryAmerican Journal of Health-System Pharmacy, 2010
- Macrolides, Ketolides, and Glycylcyclines: Azithromycin, Clarithromycin, Telithromycin, TigecyclineInfectious Disease Clinics of North America, 2009
- Azithromycin-induced hepatoxicityThe American Journal of Medicine, 2005
- Hepatotoxicity of Antimicrobial AgentsSeminars in Liver Disease, 2002
- A 33-Year-Old Woman with Jaundice after Azithromycin UseSeminars in Liver Disease, 2002
- Development and validation of a clinical scale for the diagnosis of drug-induced hepatitisJournal of Hepatology, 1997
- Antibacterial-Induced HepatotoxicityDrug Safety, 1996
- Azithromycin Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- Cholestatic hepatitis from erythromycin ethylsuccinate report of two casesThe American Journal of Medicine, 1984